Published in Transplant Rev on January 01, 1975
Common and rare variants in multifactorial susceptibility to common diseases. Nat Genet (2008) 13.95
The histocompatibility system in juvenile, insulin-dependent diabetic multiplex kindreds. J Clin Invest (1977) 2.01
Progress report. Familial inflammatory bowel disease--heredity or environment? Gut (1976) 1.81
Extended major histocompatibility complex haplotypes in type I diabetes mellitus. J Clin Invest (1984) 1.58
HLA and disease: predictions for HLA haplotype sharing in families. Am J Hum Genet (1981) 1.44
Mixed lymphocyte culture determinants and C2 deficiency: LD-7a associated with C2 deficiency in four families. J Exp Med (1975) 1.40
Alopecia universalis as a feature of polyglandular autoimmunity type I. West J Med (1988) 1.38
On the pathogenesis of IDDM. Diabetologia (1994) 1.02
The HLA system in the families of patients with juvenile diabetes mellitus. J Exp Med (1976) 0.98
Autoantibodies, histocompatibility antigens and testosterone in males with alcoholic liver cirrhosis. Clin Exp Immunol (1981) 0.93
HLA class II alpha chain gene polymorphisms in patients with insulin-dependent diabetes mellitus, dermatitis herpetiformis, and celiac disease. J Clin Invest (1987) 0.86
Expanded dog leukocyte antigen (DLA) single nucleotide polymorphism (SNP) genotyping reveals spurious class II associations. Vet J (2011) 0.84
An islet cell antibody negative form of insulin-dependent diabetes mellitus (IDD) associated with HLA antigens A9 and Bw16. Clin Exp Immunol (1982) 0.83
Immunological features of juvenile onset diabetic patients correlated to HLA type. Clin Exp Immunol (1979) 0.79
Thygeson's superficial punctate keratitis: natural history and association with HLA DR3. Trans Am Ophthalmol Soc (1981) 0.79
Association of low C2 and C4 serum levels with the HLA-DW2 allele in healthy individuals. J Exp Med (1978) 0.79
Human histocompatibility antigen associations in subacute cutaneous lupus erythematosus. J Clin Invest (1981) 0.78
Editorial: Heritability of diabetes. Br Med J (1975) 0.75
Confounding factors in HLA-DW 2 typing of human leucocytes. Clin Exp Immunol (1977) 0.75
A 'new' DR4 associated D specificity 'JA' in type 1 (insulin-dependent) diabetes: A9, Bw16, DJA, DR4 haplotype. Diabetologia (1984) 0.75
Plasminogen activators, tissue degradation, and cancer. Adv Cancer Res (1985) 8.64
HL-A antigens and diabetes mellitus. Lancet (1974) 4.42
HL-A antigens and disease. Statistical and genetical considerations. Tissue Antigens (1974) 4.41
HLA and disease 1982--a survey. Immunol Rev (1983) 3.87
Effects of the early administration of enalapril on mortality in patients with acute myocardial infarction. Results of the Cooperative New Scandinavian Enalapril Survival Study II (CONSENSUS II) N Engl J Med (1992) 3.87
Interplay between promoter and structural gene variants control basal serum level of mannan-binding protein. J Immunol (1995) 3.30
Addison's disease--clinical studies. A report fo 108 cases. Acta Endocrinol (Copenh) (1974) 3.24
Nomenclature for factors of the HLA system, 2010. Tissue Antigens (2010) 3.22
Suggestion of linkage of a major locus for nonsyndromic orofacial cleft with F13A and tentative assignment to chromosome 6. Clin Genet (1987) 3.14
A TaqI polymorphism in the human interleukin-1 beta (IL-1 beta) gene correlates with IL-1 beta secretion in vitro. Eur J Clin Invest (1992) 2.99
Linkage relationships of paraoxonase (PON) with other markers: indication of PON-cystic fibrosis synteny. Clin Genet (1985) 2.96
HL-A and disease associations--a survey. Transplant Rev (1975) 2.87
A humanized model for multiple sclerosis using HLA-DR2 and a human T-cell receptor. Nat Genet (1999) 2.85
Cytotoxicity of human pI 7 interleukin-1 for pancreatic islets of Langerhans. Science (1986) 2.83
Mice lacking all conventional MHC class II genes. Proc Natl Acad Sci U S A (1999) 2.83
Dual effect of CCR5 delta 32 gene deletion in HIV-1-infected patients. Copenhagen AIDS Study Group. Lancet (1997) 2.70
Mannose-binding lectin polymorphisms and susceptibility to infection in systemic lupus erythematosus. Arthritis Rheum (1999) 2.66
Histocompatibility determinants in multiple sclerosis, with special reference to clinical course. Lancet (1973) 2.41
Effects of xanomeline, a selective muscarinic receptor agonist, on cognitive function and behavioral symptoms in Alzheimer disease. Arch Neurol (1997) 2.35
Prevalence of left ventricular hypertrophy in a general population; The Tromsø Study. Eur Heart J (1999) 2.32
Increased frequency of homozygosity of abnormal mannan-binding-protein alleles in patients with suspected immunodeficiency. Lancet (1995) 2.31
A new frequent allele is the missing link in the structural polymorphism of the human mannan-binding protein. Immunogenetics (1994) 2.31
Association of mannose-binding lectin gene heterogeneity with severity of lung disease and survival in cystic fibrosis. J Clin Invest (1999) 2.24
HLA and disease associations: detecting the strongest association. Tissue Antigens (1994) 2.22
The predisposition to type 1 diabetes linked to the human leukocyte antigen complex includes at least one non-class II gene. Am J Hum Genet (1999) 2.17
Different molecular events result in low protein levels of mannan-binding lectin in populations from southeast Africa and South America. J Immunol (1998) 2.11
HL-A antigens and multiple sclerosis. Lancet (1972) 2.09
Percutaneous transluminal coronary angioplasty versus thrombolysis in acute myocardial infarction. Scand Cardiovasc J (2000) 2.03
Intracellular studies in the facial nucleus illustrating a simple new method for obtaining viable motoneurons in adult rat brain slices. Synapse (1989) 1.99
HLA-D region beta-chain DNA endonuclease fragments differ between HLA-DR identical healthy and insulin-dependent diabetic individuals. Nature (1983) 1.99
Transforming growth factor-beta is a strong and fast acting positive regulator of the level of type-1 plasminogen activator inhibitor mRNA in WI-38 human lung fibroblasts. EMBO J (1987) 1.98
Ultrastructural localization of plasma membrane-associated urokinase-type plasminogen activator at focal contacts. J Cell Biol (1988) 1.97
Anti-adrenal, cellular hypersensitivity in Addison's disease. Clin Exp Immunol (1969) 1.95
Association of tumor necrosis factor (TNF) and class II major histocompatibility complex alleles with the secretion of TNF-alpha and TNF-beta by human mononuclear cells: a possible link to insulin-dependent diabetes mellitus. Eur J Immunol (1993) 1.95
Susceptibility to HIV infection and progression of AIDS in relation to variant alleles of mannose-binding lectin. Lancet (1997) 1.92
Identification of a novel TGF-beta-regulated gene encoding a putative zinc finger protein in human osteoblasts. Nucleic Acids Res (1995) 1.89
Nomenclature for factors of the HLA system, 2002. Tissue Antigens (2002) 1.89
Purification of zymogen to plasminogen activator from human glioblastoma cells by affinity chromatography with monoclonal antibody. Biochemistry (1982) 1.85
Followup study on patients with Reiter's disease and reactive arthritis, with special reference to HLA-B27. Arthritis Rheum (1982) 1.83
A ten- to 15-year follow-up of the cementless spotorno stem. J Bone Joint Surg Br (2003) 1.82
HLA genotype distribution and genetic models of insulin-dependent diabetes mellitus. Ann Hum Genet (1981) 1.78
Anti-pancreatic cellular hypersensitivity in diabetes mellitus. Diabetes (1971) 1.77
Relative predispositional effects of HLA class II DRB1-DQB1 haplotypes and genotypes on type 1 diabetes: a meta-analysis. Tissue Antigens (2007) 1.77
Restriction fragment length polymorphism of the insulin gene in diabetes mellitus. Diabetes (1982) 1.75
Genetics of HLA disease association. Annu Rev Genet (1981) 1.74
Human tumor necrosis factor potentiates human interleukin 1-mediated rat pancreatic beta-cell cytotoxicity. J Immunol (1987) 1.74
Rapid changes in chromatographically determined haemoglobin A1c induced by short-term changes in glucose concentration. Diabetologia (1980) 1.71
Human cell-mediated cytotoxicity against modified target cells is restricted by HLA. Nature (1977) 1.69
Plasminogen activator inhibitor type-1: reactive center and amino-terminal heterogeneity determined by protein and cDNA sequencing. FEBS Lett (1986) 1.68
Studies of the HLA system and insulin-dependent diabetes mellitus. Diabetes Care (1980) 1.63
High performance liquid chromatography method for rapid and accurate determination of homocysteine in plasma and serum. Eur J Clin Chem Clin Biochem (1991) 1.62
Association of mannose-binding-lectin deficiency with severe atherosclerosis. Lancet (1998) 1.62
Relationship between insulin injection regimen and metabolic control in young Danish type 1 diabetic patients. The Danish Study Group of Diabetes in Childhood. Diabet Med (1992) 1.60
Effect of thapsigargin on cytoplasmic Ca2+ and proliferation of human lymphocytes in relation to AIDS. Biochim Biophys Acta (1988) 1.59
Mitral flow derived Doppler indices of left ventricular diastolic function in a general population; the Tromso study. Eur Heart J (2000) 1.58
Nomenclature for factors of the HLA system, 2004. Tissue Antigens (2005) 1.57
Serum cobalamin, homocysteine, and methylmalonic acid concentrations in a multiethnic elderly population: ethnic and sex differences in cobalamin and metabolite abnormalities. Am J Clin Nutr (1999) 1.55
Glycosylated haemoglobin and steady-state mean blood glucose concentration in Type 1 (insulin-dependent) diabetes. Diabetologia (1982) 1.54
Influence of the development of diabetes mellitus on clinical status in patients with cystic fibrosis. Eur J Pediatr (1992) 1.52
Plasminogen activator inhibitor from human fibrosarcoma cells binds urokinase-type plasminogen activator, but not its proenzyme. J Biol Chem (1986) 1.51
Glucose tolerance in patients with cystic fibrosis: five year prospective study. BMJ (1995) 1.50
CC chemokine receptor 5 polymorphism in rheumatoid arthritis. J Rheumatol (1998) 1.50
Dual role of mannan-binding protein in infections: another case of heterosis? Eur J Immunogenet (1994) 1.50
Diabetes mellitus in cystic fibrosis: effect of insulin therapy on lung function and infections. Acta Paediatr (1994) 1.50
Evidence of a non-MHC susceptibility locus in type I diabetes linked to HLA on chromosome 6. Am J Hum Genet (1997) 1.48
Constitutive activation of a slowly migrating isoform of Stat3 in mycosis fungoides: tyrphostin AG490 inhibits Stat3 activation and growth of mycosis fungoides tumor cell lines. Proc Natl Acad Sci U S A (1997) 1.47
Genes in the HLA class I region may contribute to the HLA class II-associated genetic susceptibility to multiple sclerosis. Tissue Antigens (2004) 1.47
Prevalence of diabetic autonomic neuropathy measured by simple bedside tests. Diabetologia (1981) 1.46
The HL-A7 histocompatibility antigen in sarcoidosis in relation to tuberculin sensitivity. Tissue Antigens (1975) 1.45